Pituitary Carcinoma: The University of Texas MD Anderson Cancer Center Experience.
F. Santos-Pinheiro, M. Penas-Prado, C. Kamiya-Matsuoka, S. G. Waguespack, A. Mahajan, P. D. Brown, K. B. Shah, G. N. Fuller, I. E. McCutcheon
This study reports on 17 pituitary carcinoma patients treated at MDACC, finding that TMZ-based therapy correlates with longer disease control and higher survival rates.
bioRxiv · Sep 10, 2018Cancer Biology